Course Outline
Click on the links below to preview selected pages from this course.
- The 2016 WHO Revision of Hematologic Malignancies
- Introduction to the 2016 WHO Classification of Myeloid and Lymphoid Neoplasms
- 2016 WHO Classification of Lymphoid Neoplasms
- The 2016 WHO Classification of Myeloid Neoplasms
- How and why were the lymphoid and myeloid neoplasms reclassified in 2016?
- A Three Year Old with Acute Lymphoblastic Leukemia: A Review of Current and New Diagnostic Tests
- 3 Year Old Child Presenting with Bruising, Lethargy, and Fever
- Interpretation of CBC and Additional Testing
- Immunophenotyping in ALL
- Cytogenetic Analysis
- Molecular Testing
- Discussion of Childhood Acute Lymphoblastic Leukemia
- Immunophenotyping is a useful diagnostic technique to determine cell lineage in acute leukemias. Specifically, this technique detects which of the fol...
- Some favorable factors (i.e., good prognosis) in childhood leukemias include which of the following?
- What is the percentage of blasts that trigger a diagnosis of acute leukemia?
- A 72 Year Old Male with Multiple Myeloma
- Controversial Diagnosis of Essential Thrombocythemia of a 68-Year-Old Patient
- Initial Laboratory Tests and Presenting Symptoms
- Results of Follow-up Tests and More Testing
- More Tests and a Diagnosis
- Pathophysiology of Essential Thrombocythemia (ET)
- Symptoms and Treatment of ET
- Is This Really the Correct Diagnosis?
- Common laboratory findings at initial diagnosis of Essential Thrombocythemia (ET) include:
- The following criteria must be excluded in order to establish a diagnosis of ET:
- Which of the following diseases is difficult to distinguish from ET?
- A 77 Year Old Man with Dysplasia and Blasts: Myelodysplastic Syndrome with Excess Blasts-2 (MDS-EB-2)
- Symptoms and Initial CBC
- Differential
- Discussion of Results and Further Testing
- Definitive Diagnosis
- Pathophysiology of Myelodysplastic Syndromes (MDS)
- Pathophysiology of MDS-EB2
- Clinical Course, Prognosis and Treatment of MDS-EB2
- Check all the lab results that can be seen in Myelodysplastic Syndromes (MDS):
- Which of the following myelodysplastic syndromes (MDS) is most likely to lead to Acute Myeloid Leukemia (AML)?
- Which of the following abnormal white blood cells can be seen in MDS-EB2?
- References
Additional Information
Level of instruction: Intermediate
Intended Audience: Medical laboratory scientists, medical laboratory technicians, laboratory supervisors, and laboratory managers. This course is also appropriate for MLS and MLT students and pathology residents.
Author Information: Margaret Reinhart, MS, MLS(ASCP), is an adjunct instructor of Hematology at the Pennsylvania Hospital Medical Laboratory Science program, which is part of the Hospital of the University of Pennsylvania. From 1990 to 2020, she was the Medical Laboratory Science Program director at the University of the Sciences.
Reviewer Information: Rory Huschka, M.Ed., MT(ASCP), has over 20 years of experience as a medical technologist, technical supervisor, professor, and manager. He is the former Director of Medical Laboratory Science and Medical Laboratory Technician Programs at Brookline College. He is currently a Program Director at MediaLab, Inc. Rory holds a BS degree in Medical Technology from North Dakota State University and a Master's in Educational Leadership.
Course Description: This course presents case studies about malignant/neoplastic disorders. Each case is given, followed by several pertinent questions. Answers for each question are then provided, along with a brief discussion to explain these answers. The course taker will then be able to answer questions based on the concepts learned in the case.
